A Single-Nucleotide Polymorphism in CYP2B6 Leads to >3-Fold Increases in Efavirenz Concentrations in Plasma and Hair Among HIV-Infected Women

Microanalysis of the antiretroviral nevirapine in human hair from HIV-infected patients by liquid chromatography-tandem mass spectrometry

(2011) Yong Huang et al.   ANALYTICAL AND BIOANALYTICAL CHEMISTRY

Population Pharmacokinetic/Pharmacogenetic Model for Optimization of Efavirenz Therapy in Caucasian HIV-Infected Patients

(2011) Almudena Sánchez et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Atazanavir Concentration in Hair Is the Strongest Predictor of Outcomes on Antiretroviral Therapy

(2011) M. Gandhi et al.   CLINICAL INFECTIOUS DISEASES

CYP2B6 genotype is a strong predictor of systemic exposure to efavirenz in HIV-infected Zimbabweans

(2011) Milimo Maimbo et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Cytochrome P450 2B6 (CYP2B6) and constitutive androstane receptor (CAR) polymorphisms are associated with early discontinuation of efavirenz-containing regimens

(2011) C. Wyen et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Genomics and Drug Response

(2011) Liewei Wang et al.   NEW ENGLAND JOURNAL OF MEDICINE

Efavirenz Plasma Concentrations and Cytochrome 2B6 Polymorphisms

(2010) Tristan Lindfelt et al.   ANNALS OF PHARMACOTHERAPY

A comparison of the long-term durability of nevirapine, efavirenz and lopinavir in routine clinical practice in Europe: a EuroSIDA study

(2010) J Reekie et al.   HIV MEDICINE

Effect ofCYP2B6,ABCB1, andCYP3A5Polymorphisms on Efavirenz Pharmacokinetics and Treatment Response: An AIDS Clinical Trials Group Study

(2010) Heather J. Ribaudo et al.   JOURNAL OF INFECTIOUS DISEASES

Association of Pharmacogenetic Markers with Premature Discontinuation of First-line Anti-HIV Therapy: An Observational Cohort Study

(2010) Rubin Lubomirov et al.   JOURNAL OF INFECTIOUS DISEASES

Protease inhibitor levels in hair strongly predict virologic response to treatment

(2009) Monica Gandhi et al.   AIDS

Influence of the Cytochrome P450 2B6 Genotype on Population Pharmacokinetics of Efavirenz in Human Immunodeficiency Virus Patients

(2009) S. E. Cabrera et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Pharmacogenetics-Based Population Pharmacokinetic Analysis of Efavirenz in HIV-1-Infected Individuals

(2009) M Arab-Alameddine et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Nonnucleoside Reverse Transcriptase Inhibitor Pharmacokinetics in a Large Unselected Cohort of HIV-Infected Women

(2009) Monica Gandhi et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Simplification of Antiretroviral Therapy to a Single-Tablet Regimen Consisting of Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate Versus Unmodified Antiretroviral Therapy in Virologically Suppressed HIV-1-Infected Patients

(2009) Edwin DeJesus et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Associations betweenCYP2B6Polymorphisms and Pharmacokinetics after a Single Dose of Nevirapine or Efavirenz in African Americans

(2009) David W. Haas et al.   JOURNAL OF INFECTIOUS DISEASES

In vivo analysis of efavirenz metabolism in individuals with impaired CYP2A6 function

(2009) Julia di Iulio et al.   Pharmacogenetics and Genomics

The pharmacokinetics and pharmacogenomics of efavirenz and lopinavir/ritonavir in HIV-infected persons requiring hemodialysis

(2008) Samir K Gupta et al.   AIDS

Optimizing efavirenz treatment: CYP2B6 genotyping or therapeutic drug monitoring?

(2008) Margalida Rotger et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

“White Coat Compliance” Limits the Reliability of Therapeutic Drug Monitoring in HIV-1—Infected Patients

(2008) Thomas J. Podsadecki et al.   HIV CLINICAL TRIALS

A panel of ancestry informative markers for estimating individual biogeographical ancestry and admixture from four continents: utility and applications

(2008) Indrani Halder et al.   HUMAN MUTATION

Sensitive analysis of anti-HIV drugs, efavirenz, lopinavir and ritonavir, in human hair by liquid chromatography coupled with tandem mass spectrometry

(2008) Yong Huang et al.   RAPID COMMUNICATIONS IN MASS SPECTROMETRY